Education
About Us
Working with TipRanks
Follow Us
SelectQuote (SLQT)
NYSE:SLQT
Earnings Data
Report Date
May 07, 2026After Close (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
0.06Last Year’s EPS
0.11Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call described strong operational execution: double‑digit consolidated revenue growth, near‑record senior margins (39%), rapid SelectRx revenue growth (26% YoY) and measurable clinical outcomes (20% fewer hospital days). Management secured a multiyear PBM agreement and a $415M credit facility that materially improves visibility and capital flexibility. However, the quarter and fiscal 2026 guidance were meaningfully impacted by two discrete headwinds (~$20M PBM reimbursement adjustment and ~$20M from a national carrier marketing cut), prompting a revised adjusted EBITDA range of $90–$100M and signaling near‑term uncertainty from industry disruption and preliminary CMS rate guidance. Overall the operational and cash flow improvements and strategic balance sheet actions outweigh the near‑term, largely one‑time headwinds, leaving management optimistic about long‑term profitability and cash generation.Company Guidance
Consolidated Revenue Growth
Consolidated revenue grew 12% year-over-year to $537 million in the quarter.
Senior Segment Profitability and Volume
Senior revenue was $262 million, up 2% YoY; approved policy volume growth of 4%; senior adjusted EBITDA was $102 million and senior EBITDA margin was a near‑record 39% (fourth consecutive AEP season >30%).
Agent Productivity and Retention
Agent retention remained north of 90%; productivity per agent was 12% higher than two years ago despite a higher mix of new hires.
Marketing Efficiency
Marketing cost per approved policy was $326, in line with last year and ~20% lower versus 02/2024, contributing to strong marketing efficiency.
Health Care Services (SelectRx) Rapid Growth
SelectRx members grew 17% YoY to 113,000 and revenue grew 26% YoY to $231 million as onboarding members matured and consumed full prescriptions.
Clinical Outcomes and Operational Impact of SelectRx
SelectRx pharmacists identified nearly 50,000 potential dosage or adverse interaction concerns in 2025, leading to tens of thousands of prescription changes and an observed 20% reduction in beneficiary hospital days tied to improved medication adherence.
Improved Capital Flexibility
Closed a new $415 million credit facility in January that extends debt maturities to 2031, increases peak season liquidity, and provides optionality to lower interest cost (up to 100 bps) and fund strategic initiatives.
PBM Multiyear Agreement
Entered a multiyear PBM agreement that materially improves visibility into drug reimbursement pricing, supporting SelectRx profitability and predictability moving forward.
Cash Flow Improvement
Management expects operating cash flow of $25 million to $35 million for fiscal 2026 (midpoint stated as >$40 million higher than last year) and forecasts ~20% increase in cash EBITDA for 2026 versus prior year.
Life Insurance Performance
Life revenue grew 9% to $44 million; final expense premiums increased 24% YoY; Life adjusted EBITDA was $6 million, continuing to deliver attractive returns and cash flow.
SLQT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SLQT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 05, 2026 | $1.45 | $1.03 | -28.97% |
Nov 06, 2025 | $2.13 | $1.68 | -21.13% |
Aug 21, 2025 | $1.83 | $2.59 | +41.53% |
May 12, 2025 | $2.67 | $2.35 | -11.99% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does SelectQuote (SLQT) report earnings?
SelectQuote (SLQT) is schdueled to report earning on May 07, 2026, After Close (Confirmed).
What is SelectQuote (SLQT) earnings time?
SelectQuote (SLQT) earnings time is at May 07, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SLQT EPS forecast?
SLQT EPS forecast for the fiscal quarter 2026 (Q3) is 0.06.